| NO. | Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 08:00-08:06 |
Chemotherapy plus concurrent irreversible electroporation improved local tumor control in unresectable hilar cholangiocarcinoma compared with chemotherapy alone |
Yang-Yang Ma | Fuda Cancer Hospital, China |
| 2 | 08:08-08:14 |
Efficacy of cryoablation combined with sorafenib for the treatment of advanced renal cell carcinoma |
Yu-Qing Xu | Tianjin Medical University Cancer Institute & Hospital, China |
| 3 | 08:16-08:22 |
Radioactive iodine-125 particle implantation combined with transarterial chemoinfusion and synchronous immune checkpoint inhibitors for the management of locally advanced pancreatic cancer: a retrospective single-center analysis |
Bin Li | Beijing Hospital, China |
| 4 | 08:24-08:30 |
Antegrade DJ Stenting in Obstructive Ureteric Calculus After Failed Retrograde Access: A Radiology-Driven Management Approach |
Md Alauddin Saddam | Interventional Radiology, Bangladesh |
| 5 | 08:40-08:46 |
Liquid glue or solid particles? Randomized trial comparing embolic agents for bronchial artery embolization in patients with haemoptysis. |
Vineeth Kurki Manjunath | Narayana Health City, India |
| 6 | 08:48-08:54 |
The role of interventional radiology methods in the treatment of portal hypertension in Kazakhstan. Single-center study. |
Niyaz Malayev | National Scientific Medical Center, Kazakhstan |
| 7 | 08:56-09:02 |
When Injury Meets Disease: Endovascular Stenting of Traumatic versus Atherosclerotic Celiac Artery Dissection |
Jayson Naguit | Philippine Society of Vascular and Interventional Radiology, Philippines |
| 8 | 09:12-09:18 |
ENDOVASCULAR TREATMENT FOR MANAGEMENT SPLANCHNIC CIRCULATION ANEURYSM: EXPERIENCE AT CHO RAY HOSPITAL |
Bao Van Tien Nguyen | Cho Ray Hospital, Ho Chi Minh City, Vietnam |
| NO. | Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 10:08-10:14 |
Immune microenvironment remodeling in patients with unresectable hepatocellular carcinoma pre- versus post- transarterial chemoembolization combined with tyrosine kinase inhibitors and immune checkpoint inhibitors: insights from single-cell transcriptomic profiling |
Hai-Feng Zhou | Jiangsu Province Hospital (The First Affilated Hospital with Nanjing Medical University), China |
| 2 | 10:16-10:22 |
Clinical efficacy of HAIC (RALOX) combined with systemic therapy vs. TACE combined with systemic therapy in the treatment of advanced hepatocellular carcinoma with arterioportal fistulas |
Ru-Jian Wang | The Affiliated Yantai Yuhuangding Hospital of Qingdao University, China |
| 3 | 10:24-10:30 |
Two Cases of Hepatocellular Carcinoma Rupture Following Transarterial Chemoembolization with Radiopaque Small-caliber Drug-eluting Microspheres |
Xin-Ran Guo | Chengdu Medical College, China |
| 4 | 10:32-10:38 |
Efficacy, Survival, and Cost-effectiveness Associated With cTACE vs DEB-TACE for Treatment of Solitary Large HCC: A Propensity-Matched Study |
Mu Ding | Binzhou Medical University Hospital, China |
| 5 | 10:48-10:54 |
Prediction of overall survival in unresectable HCC receiving TACE plus atezolizumab and bevacizumab: A multicenter retrospective study |
Li-Wei Deng | The Cancer Institute and Hospital, Chinese Academy of Medical Sciences (CAMS), China |
| 6 | 10:56-11:02 |
Multiscale Intra- and Peritumoral MRI Radiomics Combined with Pathological Spatial Heterogeneity for Recurrence Prediction in Hepatocellular Carcinoma After Resection and Adjuvant TACE |
Chun-Li Kong | The Fifth Affiliated Hospital of Wenzhou Medical University, China |
| 7 | 11:04-11:10 |
Efficacy and Safety of TACE With or Without MWA Followed by Sequential Targeted and Immunotherapy in HCC Beyond the UP-to-7 Criteria |
Yang Fang | The Affiliated Hospital of Yanbian University Yanbian Hospital, China |